IMMUNEERING CORPORATION - CLASS A COMMON STOCK
4.2200
10-July-25 11:26:11
15 minutes delayed
Stocks
-0.2300
-5.17%
Today's range
4.2200 - 4.5900
ISIN
N/A
Source
NASDAQ
-
09 Jul 2025 05:00:00 By Nasdaq GlobeNewswire
-
17 Jun 2025 03:00:00 By Nasdaq GlobeNewswire
-
16 Jun 2025 05:00:00 By Nasdaq GlobeNewswire
-
Immuneering to Present at the Jefferies Global Healthcare Conference
29 May 2025 05:01:11 By Nasdaq GlobeNewswire
-
Immuneering Reports First Quarter 2025 Financial Results and Provides Business Updates
05 May 2025 13:05:00 By Nasdaq GlobeNewswire
-
Immuneering to Present at the 24th Annual Needham Virtual Healthcare Conference
02 Apr 2025 05:00:00 By Nasdaq GlobeNewswire
-
Immuneering Corporation Announces Grant of Inducement Award
21 Mar 2025 13:30:09 By Nasdaq GlobeNewswire
-
20 Mar 2025 13:05:00 By Nasdaq GlobeNewswire
-
Immuneering Names Dr. Igor Matushansky as Chief Medical Officer
20 Mar 2025 04:00:00 By Nasdaq GlobeNewswire
-
06 Feb 2025 04:00:00 By Nasdaq GlobeNewswire
-
Immuneering to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
03 Feb 2025 13:05:03 By Nasdaq GlobeNewswire
-
13 Jan 2025 05:00:01 By Nasdaq GlobeNewswire
-
07 Jan 2025 04:00:00 By Nasdaq GlobeNewswire
-
Immuneering Launches Pancreatic Cancer Advisory Board
19 Dec 2024 05:00:00 By Nasdaq GlobeNewswire
-
17 Dec 2024 05:00:00 By Nasdaq GlobeNewswire
-
Immuneering Granted FDA Fast Track Designation for IMM-1-104 in Advanced Melanoma
12 Dec 2024 05:00:00 By Nasdaq GlobeNewswire
-
Immuneering to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference
27 Nov 2024 05:00:00 By Nasdaq GlobeNewswire
-
Immuneering Reports Third Quarter 2024 Financial Results and Provides Business Updates
13 Nov 2024 13:05:00 By Nasdaq GlobeNewswire
-
15 Oct 2024 05:00:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >